- Home
- NAGE vs PHAR Comparison
NAGE vs PHAR Comparison
Compare NAGE & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NAGE
- PHAR
- Stock Information
- Founded
- NAGE 1999
- PHAR 1988
- Country
- NAGE United States
- PHAR Netherlands
- Employees
- NAGE N/A
- PHAR N/A
- Industry
- NAGE Medicinal Chemicals and Botanical Products
- PHAR Biotechnology: Pharmaceutical Preparations
- Sector
- NAGE Health Care
- PHAR Health Care
- Exchange
- NAGE Nasdaq
- PHAR Nasdaq
- Market Cap
- NAGE 594.0M
- PHAR 587.5M
- IPO Year
- NAGE N/A
- PHAR N/A
- Fundamental
- Price
- NAGE $6.76
- PHAR N/A
- Analyst Decision
- NAGE Strong Buy
- PHAR Strong Buy
- Analyst Count
- NAGE 1
- PHAR 3
- Target Price
- NAGE $11.00
- PHAR $30.00
- AVG Volume (30 Days)
- NAGE 665.7K
- PHAR 4.6K
- Earning Date
- NAGE 05-07-2025
- PHAR 05-08-2025
- Dividend Yield
- NAGE N/A
- PHAR N/A
- EPS Growth
- NAGE N/A
- PHAR N/A
- EPS
- NAGE 0.11
- PHAR N/A
- Revenue
- NAGE $99,597,000.00
- PHAR $297,200,000.00
- Revenue This Year
- NAGE $21.53
- PHAR $8.26
- Revenue Next Year
- NAGE $20.87
- PHAR $9.73
- P/E Ratio
- NAGE $61.45
- PHAR N/A
- Revenue Growth
- NAGE 19.18
- PHAR 21.15
- 52 Week Low
- NAGE $2.31
- PHAR $6.65
- 52 Week High
- NAGE $9.18
- PHAR $11.07
- Technical
- Relative Strength Index (RSI)
- NAGE N/A
- PHAR 45.53
- Support Level
- NAGE N/A
- PHAR $7.79
- Resistance Level
- NAGE N/A
- PHAR $8.51
- Average True Range (ATR)
- NAGE 0.00
- PHAR 0.47
- MACD
- NAGE 0.00
- PHAR 0.01
- Stochastic Oscillator
- NAGE 0.00
- PHAR 49.08
About PHAR Pharming Group N.V.
Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States.